You Searched For: Bis(2-hydroxyethyl)amino-tris(hydroxymethyl)methane+(BIS-TRIS)
3 885 results were found
Adopting novel technologies to improve monoclonal antibody processes
/cms/webinar_adopting_novel_technologies
Adopting novel technologies to improve monoclonal antibody processes Webinar On demand Replay Over last 20+ year there has been significant grown in monoclonal antibody drug pipeline as well as diversity of monoclonal antibody molecules. For examp...
Adopting novel technologies to improve monoclonal antibody processes
/cms/webinar_adopting_novel_technologies
Adopting novel technologies to improve monoclonal antibody processes Webinar On demand Replay Over last 20+ year there has been significant grown in monoclonal antibody drug pipeline as well as diversity of monoclonal antibody molecules. For examp...
Sanborn Manufacturing Facility
/cms/sanborn_manufacturing_facility
Sanborn Manufacturing Facility The HEPES manufacturing suite at our 60000 sq. ft. manufacturing facility in Sanborn NY USA. Core Capabilities Custom manufacturing of biological buffers amino acid derivatives and custom antibiotic solutions Industr...
Sanborn Manufacturing Facility
/cms/de/sanborn_manufacturing_facility
Sanborn Manufacturing Facility The HEPES manufacturing suite at our 60000 sq. ft. manufacturing facility in Sanborn NY USA. Core Capabilities Custom manufacturing of biological buffers amino acid derivatives and custom antibiotic solutions Industr...
Sanborn Manufacturing Facility
/cms/sanborn_manufacturing_facility
Sanborn Manufacturing Facility The HEPES manufacturing suite at our 60000 sq. ft. manufacturing facility in Sanborn NY USA. Core Capabilities Custom manufacturing of biological buffers amino acid derivatives and custom antibiotic solutions Industr...
Sanborn Manufacturing Facility
/cms/sanborn_manufacturing_facility
Sanborn Manufacturing Facility The HEPES manufacturing suite at our 60000 sq. ft. manufacturing facility in Sanborn NY USA. Core Capabilities Custom manufacturing of biological buffers amino acid derivatives and custom antibiotic solutions Industr...
Sanborn Manufacturing Facility
/cms/sanborn_manufacturing_facility
Sanborn Manufacturing Facility The HEPES manufacturing suite at our 60000 sq. ft. manufacturing facility in Sanborn NY USA. Core Capabilities Custom manufacturing of biological buffers amino acid derivatives and custom antibiotic solutions Industr...
Adopting novel technologies to improve monoclonal antibody processes
/cms/webinar_adopting_novel_technologies
Adopting novel technologies to improve monoclonal antibody processes Webinar On demand Replay Over last 20+ year there has been significant grown in monoclonal antibody drug pipeline as well as diversity of monoclonal antibody molecules. For examp...
Sanborn Manufacturing Facility
/cms/sanborn_manufacturing_facility
Sanborn Manufacturing Facility The HEPES manufacturing suite at our 60000 sq. ft. manufacturing facility in Sanborn NY USA. Core Capabilities Custom manufacturing of biological buffers amino acid derivatives and custom antibiotic solutions Industr...
Adopting novel technologies to improve monoclonal antibody processes
/cms/de/webinar_adopting_novel_technologies
Adopting novel technologies to improve monoclonal antibody processes Webinar On demand Replay Over last 20+ year there has been significant grown in monoclonal antibody drug pipeline as well as diversity of monoclonal antibody molecules. For examp...
Adopting novel technologies to improve monoclonal antibody processes
/cms/webinar_adopting_novel_technologies
Adopting novel technologies to improve monoclonal antibody processes Webinar On demand Replay Over last 20+ year there has been significant grown in monoclonal antibody drug pipeline as well as diversity of monoclonal antibody molecules. For examp...
Adopting novel technologies to improve monoclonal antibody processes
/cms/webinar_adopting_novel_technologies
Adopting novel technologies to improve monoclonal antibody processes Webinar On demand Replay Over last 20+ year there has been significant grown in monoclonal antibody drug pipeline as well as diversity of monoclonal antibody molecules. For examp...
Adopting novel technologies to improve monoclonal antibody processes
/cms/webinar_adopting_novel_technologies
Adopting novel technologies to improve monoclonal antibody processes Webinar On demand Replay Over last 20+ year there has been significant grown in monoclonal antibody drug pipeline as well as diversity of monoclonal antibody molecules. For examp...
Adopting novel technologies to improve monoclonal antibody processes
/cms/fr/webinar_adopting_novel_technologies
Adopting novel technologies to improve monoclonal antibody processes Webinar On demand Replay Over last 20+ year there has been significant grown in monoclonal antibody drug pipeline as well as diversity of monoclonal antibody molecules. For examp...
Adopting novel technologies to improve monoclonal antibody processes
/cms/webinar_adopting_novel_technologies
Adopting novel technologies to improve monoclonal antibody processes Webinar On demand Replay Over last 20+ year there has been significant grown in monoclonal antibody drug pipeline as well as diversity of monoclonal antibody molecules. For examp...
Adopting novel technologies to improve monoclonal antibody processes
/cms/webinar_adopting_novel_technologies
Adopting novel technologies to improve monoclonal antibody processes Webinar On demand Replay Over last 20+ year there has been significant grown in monoclonal antibody drug pipeline as well as diversity of monoclonal antibody molecules. For examp...
113 - 128 of 3 885